Whereas metastatic castrate-resistant prostate cancer used to have a poor prognosis, new agents are available and continuing to emerge with the potential to extend survival, but there is no ...

Recently, licensed and emerging treatments for metastatic ... a view to maximize survival as well. This article provides an overview of developments in advanced prostate cancer and considers ...

Advanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called ...

Sheel Patel, a board certified physician in hematology, oncology, and internal medicine, spoke with Healthline about how prostate cancer affects Black men, including rate of diagnosis, survival ...

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators offers new evidence that dietary changes may ...

The report, covering 2020 to 2022, examines cancer incidence and survival rates. It looks at the four most common forms of the disease in Ireland: lung, bowel, breast and prostate cancers.

SUO annual meeting included a prostate cancer session, featuring a debate regarding the management of localized radiorecurrent prostate cancer, and a presentation by Dr. Kara Watts discussing the role ...

“Progression-free survival outcomes with nivolumab plus ipilimumab were superior to those with chemotherapy in the first-line treatment of MSI-H or dMMR metastatic colorectal cancer,” the ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

Metastatic prostate cancer is associated with a significant mortality rate, with only one third of patients surviving five years after ... and clinically meaningful improvement in the primary endpoint ...